Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

13

Revenue 2017

Bristol-Myers Squibb

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Bristol-Myers Squibb's 2013 sales performance.

Bristol-Myers Squibb

Citryll snares €15m backing for its autoimmune disease NETs

Citryll snares €15m backing for its autoimmune disease NETs Other companies including Bristol-Myers Squibb (via its $600m acquisition of Padlock Therapeutics in 2016) are working on small-molecule PAD inhibitors for autoimmune disease.

Gaining Perspective: What Can the UK Learn from Lung Cancer Care in Europe?

by ENGINE MHP for Bristol-Myers Squibb. The UK’s lung cancer survival rates are some of the lowest in Europe.  To tackle this, the UK Lung Cancer Coalition (UKLCC) identified ... the possibility of learning from European health systems to improve

Illustrating Rheumatoid Arthritis

by ENGINE MHP for Bristol-Myers Squibb.

Securing Equity of Access to Cancer Medicines in Northern Ireland

by Hanover Communications for Bristol-Myers Squibb. In 2013, the Northern Ireland (NI) Government committed to follow the recommendations made by the National Institute for Health and Care Excellence (NICE). ... Securing Equity of Access to Cancer

Everolimus for Epilepsy

by Hanover Communications for Bristol-Myers Squibb. ... Securing Equity of Access to Cancer Medicines in Northern Ireland - by Hanover Communications for Bristol-Myers Squibb.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
infill healthcare communication

infill is a dynamic and innovative, international healthcare agency with >25 years' experience in delivering healthcare communication, medical education and...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics